tirzepatide cv outcomes ๐ In a large real-world study, was associated with a lower incidence of major cardiovascular vs semaglutide: ๐ Composite outcome: 1.90% vs 2.18% (HR 0.86, p=0.01) โค๏ธ New-onset heart tirzepatide cv outcomes trial cardiovascular
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 7 - Aug 12























